Cargando…
Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1
Progress through mitosis is controlled by the sequential destruction of key regulators including the mitotic cyclins and securin, an inhibitor of anaphase whose destruction is required for sister chromatid separation. Here we have used live cell imaging to determine the exact time when human securin...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173548/ https://www.ncbi.nlm.nih.gov/pubmed/12070128 http://dx.doi.org/10.1083/jcb.200111001 |
_version_ | 1782145216596148224 |
---|---|
author | Hagting, Anja den Elzen, Nicole Vodermaier, Hartmut C. Waizenegger, Irene C. Peters, Jan-Michael Pines, Jonathon |
author_facet | Hagting, Anja den Elzen, Nicole Vodermaier, Hartmut C. Waizenegger, Irene C. Peters, Jan-Michael Pines, Jonathon |
author_sort | Hagting, Anja |
collection | PubMed |
description | Progress through mitosis is controlled by the sequential destruction of key regulators including the mitotic cyclins and securin, an inhibitor of anaphase whose destruction is required for sister chromatid separation. Here we have used live cell imaging to determine the exact time when human securin is degraded in mitosis. We show that the timing of securin destruction is set by the spindle checkpoint; securin destruction begins at metaphase once the checkpoint is satisfied. Furthermore, reimposing the checkpoint rapidly inactivates securin destruction. Thus, securin and cyclin B1 destruction have very similar properties. Moreover, we find that both cyclin B1 and securin have to be degraded before sister chromatids can separate. A mutant form of securin that lacks its destruction box (D-box) is still degraded in mitosis, but now this is in anaphase. This destruction requires a KEN box in the NH(2) terminus of securin and may indicate the time in mitosis when ubiquitination switches from APC(Cdc20) to APC(Cdh1). Lastly, a D-box mutant of securin that cannot be degraded in metaphase inhibits sister chromatid separation, generating a cut phenotype where one cell can inherit both copies of the genome. Thus, defects in securin destruction alter chromosome segregation and may be relevant to the development of aneuploidy in cancer. |
format | Text |
id | pubmed-2173548 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21735482008-05-01 Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1 Hagting, Anja den Elzen, Nicole Vodermaier, Hartmut C. Waizenegger, Irene C. Peters, Jan-Michael Pines, Jonathon J Cell Biol Article Progress through mitosis is controlled by the sequential destruction of key regulators including the mitotic cyclins and securin, an inhibitor of anaphase whose destruction is required for sister chromatid separation. Here we have used live cell imaging to determine the exact time when human securin is degraded in mitosis. We show that the timing of securin destruction is set by the spindle checkpoint; securin destruction begins at metaphase once the checkpoint is satisfied. Furthermore, reimposing the checkpoint rapidly inactivates securin destruction. Thus, securin and cyclin B1 destruction have very similar properties. Moreover, we find that both cyclin B1 and securin have to be degraded before sister chromatids can separate. A mutant form of securin that lacks its destruction box (D-box) is still degraded in mitosis, but now this is in anaphase. This destruction requires a KEN box in the NH(2) terminus of securin and may indicate the time in mitosis when ubiquitination switches from APC(Cdc20) to APC(Cdh1). Lastly, a D-box mutant of securin that cannot be degraded in metaphase inhibits sister chromatid separation, generating a cut phenotype where one cell can inherit both copies of the genome. Thus, defects in securin destruction alter chromosome segregation and may be relevant to the development of aneuploidy in cancer. The Rockefeller University Press 2002-06-24 /pmc/articles/PMC2173548/ /pubmed/12070128 http://dx.doi.org/10.1083/jcb.200111001 Text en Copyright © 2002, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Hagting, Anja den Elzen, Nicole Vodermaier, Hartmut C. Waizenegger, Irene C. Peters, Jan-Michael Pines, Jonathon Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1 |
title | Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1 |
title_full | Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1 |
title_fullStr | Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1 |
title_full_unstemmed | Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1 |
title_short | Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1 |
title_sort | human securin proteolysis is controlled by the spindle checkpoint and reveals when the apc/c switches from activation by cdc20 to cdh1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173548/ https://www.ncbi.nlm.nih.gov/pubmed/12070128 http://dx.doi.org/10.1083/jcb.200111001 |
work_keys_str_mv | AT hagtinganja humansecurinproteolysisiscontrolledbythespindlecheckpointandrevealswhentheapccswitchesfromactivationbycdc20tocdh1 AT denelzennicole humansecurinproteolysisiscontrolledbythespindlecheckpointandrevealswhentheapccswitchesfromactivationbycdc20tocdh1 AT vodermaierhartmutc humansecurinproteolysisiscontrolledbythespindlecheckpointandrevealswhentheapccswitchesfromactivationbycdc20tocdh1 AT waizeneggerirenec humansecurinproteolysisiscontrolledbythespindlecheckpointandrevealswhentheapccswitchesfromactivationbycdc20tocdh1 AT petersjanmichael humansecurinproteolysisiscontrolledbythespindlecheckpointandrevealswhentheapccswitchesfromactivationbycdc20tocdh1 AT pinesjonathon humansecurinproteolysisiscontrolledbythespindlecheckpointandrevealswhentheapccswitchesfromactivationbycdc20tocdh1 |